Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients

References

• Redfield MM. Heart failure–an epidemic of uncertain proportions. N Engl J Med. 2002; 347: 1442–4
   PubMed Web of Science ®Google Scholar
• Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. The V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993; 87: VI5–16
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350: 655–63
   PubMed Web of Science ®Google Scholar
• Adams KF, Jr, Mathur VS, Gheorghiade M. B-type natriuretic peptide: From bench to bedside. Am Heart J. 2003; 145: S34–S46
   PubMed Web of Science ®Google Scholar
• de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004; 43: 1584–9
   PubMed Web of Science ®Google Scholar
• Bonow R, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med. 1992; 117: 502–10
   PubMed Web of Science ®Google Scholar
• Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Circulation. 2002; 105: 595–601
   PubMed Web of Science ®Google Scholar
• Swedberg C, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. The task force for diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for diagnosis and treatment of chronic heart failure: Update 2005. Eur Heart J. 2005; 26: 1115–40
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440–63
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's rosetta stone. J Am Coll Cardiol. 1997; 30: 8–18
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997; 30: 1527–33
   PubMed Web of Science ®Google Scholar
• Fischer Y, Filzmaier K, Stiegler H, Graf J, Fuhs S, Franke A, et al. Evaluation of a new rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem. 2001; 47: 591–4
   PubMed Web of Science ®Google Scholar
• Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991; 83: 778–86
   PubMed Web of Science ®Google Scholar
• Hansen A, Haass M, Zugck C, Krueger C, Unnebrink K, Zimmermann R, et al Prognostic value of Doppler echocardiographic mitral inflow patterns: Implications for risk stratification in patients with congestive heart failure. J Am Coll Cardiol. 2001;37:1049–55.
   PubMed Web of Science ®Google Scholar
• Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993; 22: 808–15
   PubMed Web of Science ®Google Scholar
• Hadano Y, Murata K, Yamamoto T, Kunichika H, Matsumoto T, Akagawa E, et al Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function. Am J Cardiol. 2006;97:1025–8.
   PubMed Web of Science ®Google Scholar
• Pepi M, Agostoni PG, Marenzi GC, Doria E, Guazzi M, Lauri G, et al The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease. Eur J Heart Failure. 1999;1:161–7.
   PubMed Web of Science ®Google Scholar
• Szlachcic Z, Massie B, Kramer B, Topie N, Tubau J. Correlates and prognosis implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985; 55: 1037–42
   PubMed Web of Science ®Google Scholar
• Clarkson PB, Wheeldon NM, MacFadyen RJ, et al. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation. 1996; 93: 2037–42
   PubMed Web of Science ®Google Scholar
• Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: Correlation with cardiac function, hemodynamics, and workload. Am Heart J. 2004; 148: 365–70
   PubMed Web of Science ®Google Scholar
• McNairy M, Gardetto N, Clopton P, Garcia A, Krishnaswamy P, Kazanegra R, et al Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J. 2002;143:406–11.
   PubMed Web of Science ®Google Scholar
• Kruger S, Graf J, Merx MW, Stickel T, Kunz D, Hanrath P, et al. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol. 2004; 95: 49–54
   PubMed Web of Science ®Google Scholar
• Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and early m RNA turnover of BNP in cardiocyte hypertrophy: Evidence for BNP as an “emergency” cardiac hormone against ventricular overload. J Clin Invest. 1995; 96: 1280–7
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M, et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 1995; 129: 139–45
   PubMed Web of Science ®Google Scholar